NCT03449745View on ClinicalTrials.gov

Immune Checkpoint Receptors in AML-Leukemic Initiating Cells

CompletedOBSERVATIONAL

Enrollment

199

Participants

Timeline

Start Date

May 29, 2018

Primary Completion Date

June 9, 2021

Study Completion Date

June 9, 2021

Conditions

Acute Myeloid Leukemia

Trial Locations (1)

Unknown

CHU de Bordeaux, Bordeaux

All Listed Sponsors

lead

University Hospital, Bordeaux

OTHER

NCT03449745 - Immune Checkpoint Receptors in AML-Leukemic Initiating Cells | Biotech Hunter | Biotech Hunter